RESUMEN
Background: There has been an increase in certain cancers among young adults (YA) aged 20-39, particularly in Latin America. This is the first study to examine cancer incidence and mortality in YA in Costa Rica, focusing on sex-specific patterns. Methods: Invasive cancer cases (excluding non-melanoma skin cancer) in YA from 2006 to 2015 were obtained from the Costa Rican National Registry of Tumors. Utilising SEER∗Stat software, age-standardized incidence rates (IRs) and incidence rate ratios (IRRs) were calculated. Trends and annual percent changes (APCs) in IRs were estimated using the Joinpoint regression analysis program. Cancer deaths from 2000 to 2021 were obtained from the Costa Rican National Institute of Statistics and Census. Age-standardised mortality rates were calculated using STATA®17. Findings: YA comprised 10.7% of all invasive cancer cases diagnosed from 2006 to 2015. The age-standardized incidence rate (ASIR) of invasive cancer in YA was 50.9/100,000 person-years. The ASIR was twofold higher for females compared to males (IRR = 2.03, 95% CI:1.94, 2.13). This difference increased with age, peaking in the 35-39-year age group (IRR = 2.84, 95% CI:2.62, 3.10). Thyroid, breast, and cervical cancer were the most common in females. Testicular cancer was the most common in males. Leading causes of cancer-related deaths included cervical and breast cancer in females and stomach and brain/nervous system cancer in males. Interpretation: The study highlights sex-specific patterns in cancer incidence and mortality among YA in Costa Rica to increase understanding and improve cancer outcomes in this age group. Funding: This study was funded by the Intramural Research Program of the National Cancer Institute.
RESUMEN
This commentary delves into the evolving landscape of cancer incidence and mortality in Costa Rica, presenting a comprehensive analysis of the data. Key findings reveal a concerning upward trajectory in cancer incidence rates, placing Costa Rica at the forefront within Central America. While prostate cancer and breast cancer dominate, disparities emerge when scrutinizing gender-specific trends. Notably, stomach and cervical cancers show declines, potentially attributed to targeted interventions. However, colorectal and liver cancers witness mortality increases, necessitating strategic responses. Geographical disparities persist across provinces, highlighting the need for equitable healthcare access. In conclusion, this commentary underscores the urgency of addressing the burgeoning cancer burden in Costa Rica, calling for evidence-based interventions and collaborative efforts on a global scale.
RESUMEN
PURPOSE: Cancer is a leading cause of death in the Caribbean, and the Republic of Trinidad and Tobago is no exception. Evidence suggests that cancer incidence and mortality may vary based on demographic factors across the different cancer types. This study aimed to investigate the incidence and mortality trends associated with cancer cases in Trinidad and Tobago for the period 2008-2018, across different age groups, gender, and ethnicity. METHODS: Data on 15,029 incident cancer cases were reported to the Dr. Elizabeth Quamina Cancer Registry between 2008 and 2018. The retrospective data were analyzed by sex, ancestry, and age, and were reported using Trinidad and Tobago population statistics for the period 2008-2018. RESULTS: The incidence of prostate and breast cancers was high among males and females, respectively. Among males, the highest cancer mortality was associated with prostate, lung, colon, blood, and pancreatic cancers, respectively. Among females, the highest cancer mortality was associated with breast, ovary, colon, blood, and pancreatic cancers. The frequency of occurrence of the top five cancer sites was the highest among Afro-Trinidadians followed by Indo-Trinidadians. Most females diagnosed with breast cancer were at a localized stage, while most males diagnosed with breast cancer were at a distant or regional stage. Most individuals diagnosed with blood cancer were at a distant stage. For lung and colon cancer, the stage of diagnosis for most males and females was either distant or unknown. Majority of males are diagnosed with prostate cancer at an unknown stage. CONCLUSIONS: The findings indicate highest cancer incidence and mortality occur among Afro-Trinidadians. The stage at diagnosis varies across cancer types and gender.
Asunto(s)
Neoplasias de la Mama , Neoplasias Pancreáticas , Masculino , Femenino , Humanos , Trinidad y Tobago/epidemiología , Estudios Retrospectivos , IncidenciaRESUMEN
Background Few in-depth reports on cancer epidemiology in New Mexico or the United States-Mexico border region exist. We aim to quantify cancer incidence and survival in New Mexico and the United States-Mexico border region in New Mexico. Methods Incidence and survival were obtained using SEER*Stat 8.3. The data were divided into either New Mexico, or SEER 18 (comprised of the 17 remaining regions) and then further divided by county in New Mexico and by time period. Incidence rates were age-standardized to the 2000 US census. Five-year survival was calculated for each cancer type. Kaplan-Meier survival plots were produced, and significance was determined using log-rank analysis. Results Analysis demonstrated that cancers in New Mexico are diagnosed at a lower rate with the exception of thyroid, liver, and ovarian. Survival is generally lower in New Mexico with 10 of the 14 cancers having worse survival in New Mexico. Only uterine cancer had improved survival in New Mexico (77.9% vs 74.9%, P < .001). Additionally, breast (82.2%), prostate (83.3%), lung and bronchus (13.7%), colorectal (53.7%), melanoma (80.1%), kidney and renal pelvis (61.2%), uterine (78.5%), and ovarian (41.6%) all had lower survival in the border counties. Conclusion Comparing New Mexico to the other regions in the SEER 18 database, both cancer incidence and survival are consistently lower; these findings could be explained by lower access to healthcare, which can result in underreporting and delays in diagnosis.
RESUMEN
BACKGROUND: The main evidence regarding social inequalities in cancer risk comes from industrialized countries. The aim of this manuscript was to analyze the association between cancer incidence and socioeconomic position (SEP) in a middle-income country (Costa Rica) between 2011 and 2015. METHODS: An ecological study at the level of the electoral district was conducted. The 477 districts were divided by area and wealth using the 2011 Census. The sample was defined using the National Electoral Rolls used for presidential elections of 2006 and 2010 (N = 2 798 517). 44 799 cancer cases were included coming from the Costa Rican Cancer Registry. Cox models were used. RESULTS: All cancer sites combined, we observed a positive gradient, with incidence being lower in the poorest districts than in the wealthiest (HRQ2 = 0.98 [0.93-1.03], HRQ3 = 0.92 [0.85-0.99], HRQ4 = 0.83 [0.77-0.88]). For colon, skin, breast, prostate, thyroid and other cancer sites, a positive social gradient was observed. For stomach, lung, and cervical (invasive or in-situ) cancers, a negative social gradient was found. For uterine cancer and lymphoma (no-Hodgkin), there was no significant relationship between wealth and incidence. For skin cancer, incidence was higher in rural as compared to urban areas after adjustment for wealth. For lung, cervical and uterine cancer, incidence was lower in rural as compared to urban area after adjustment for wealth. CONCLUSIONS: The all-cancer combined results were in contradiction with the international literature but confirmed recent study results in Costa Rica. It confirmed the importance of studying socioeconomic inequalities in middle-income countries.
Asunto(s)
Neoplasias/epidemiología , Sistema de Registros/estadística & datos numéricos , Población Rural/estadística & datos numéricos , Factores Socioeconómicos , Población Urbana/estadística & datos numéricos , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Costa Rica/epidemiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Neoplasias/economía , Pobreza , Factores Sexuales , Adulto JovenRESUMEN
PURPOSE: To assess the use of external beam radiotherapy in Catalonia (Spain), overall and by health management area. METHODS: We assessed radiotherapy treatments in a cohort of patients diagnosed with cancer from 2009 to 2011, using the population-based cancer registries in Girona and Tarragona. Participants had to have a minimum follow-up of 5 years from the time the cancer registry database was linked to the catalan health service database for financing radiation oncology. Outcomes included the proportion of patients receiving radiotherapy within 1 and 5 years of diagnosis. A log-binomial model was used to assess age-related trends in the use of radiotherapy by tumour site. Finally, we calculated the standardized utilization rate and 95% confidence intervals by health management area covered by the radiation oncology services, using indirect methods. RESULTS: At 1 and 5 years from diagnosis, 21.4 and 24.4% of patients, respectively, had received external beam radiotherapy. Patients aged 40-64 years had the most indications for the treatment, and there was a negative correlation between the patients' age and the use of radiotherapy for most tumour sites (exceptions were cervical, thyroid, and uterine cancers). There were no statistically significant differences in the use of radiotherapy according to th health management area. CONCLUSIONS: Population-based data show that external beam radiotherapy is underutilized in Catalonia. This situation requires a careful analysis to understand the causes, as well as an improvement of the available resources, oriented toward achieving realistic targets for the optimal use of external beam radiotherapy in our country.
Asunto(s)
Neoplasias/radioterapia , Adulto , Factores de Edad , Anciano , Estudios de Cohortes , Intervalos de Confianza , Bases de Datos Factuales/estadística & datos numéricos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/epidemiología , Radioterapia/estadística & datos numéricos , España/epidemiología , Tiempo de TratamientoRESUMEN
BACKGROUND: Cancer is the second leading cause of death in the Caribbean, including the islands of Trinidad and Tobago (TT). The population of TT consists of over 1.3 million people with diverse ancestral and sociocultural backgrounds, both of which may influence cancer incidence and mortality. The objective of this study was to examine incidence and mortality patterns and trends in TT. METHODS: Cancer surveillance data on 29,512 incident cancer cases reported to the Dr. Elizabeth Quamina Cancer Registry (population-based cancer registry of TT) between 1995 and 2009 were analyzed. Age-standardized rates, overall and by sex, ancestry, and geography, were reported. RESULTS: The highest incidence and mortality rates were observed for cancers related to reproductive organs in women, namely, breast, cervical, and uterine cancers, and prostate, lung and colorectal cancers among men. Average incidence rates were highest in areas covered by the Tobago Regional Health Authority (TRHA) (188 per 100,000), while average mortality rates were highest in areas covered by the North West Regional Health Authority (108 per 100,000). Nationals of African ancestry exhibited the highest rates of cancer incidence (243 per 100,000) and mortality (156 per 100,000) compared to their counterparts who were of East Indian (incidence, 125 per 100,000; mortality, 66 per 100,000) or mixed ancestry (incidence, 119 per 100,000; mortality, 66 per 100,000). CONCLUSIONS: Our findings highlight the need for national investment to improve the understanding of the epidemiology of cancer in Trinidad and Tobago, and to ultimately guide much needed cancer prevention and control initiatives in the near future.
Asunto(s)
Neoplasias/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Detección Precoz del Cáncer , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias/mortalidad , Neoplasias/prevención & control , Trinidad y Tobago/epidemiologíaRESUMEN
PURPOSE: In Trinidad and Tobago (TT), prostate cancer (CaP) is the most commonly diagnosed malignancy and the leading cause of cancer deaths among men. TT currently has one of the highest CaP mortality rates in the world. METHODS: 6,064 incident and 3,704 mortality cases of CaP occurring in TT from January 1995 to 31 December 2009 reported to the Dr. Elizabeth Quamina Cancer population-based cancer registry for TT, were analyzed to examine CaP survival, incidence, and mortality rates and trends by ancestry and geography. RESULTS: The age-standardized CaP incidence and mortality rates (per 100,000) based on the 1960 world-standardized in 2009 were 64.2 and 47.1 per 100,000. The mortality rate in TT increased between 1995 (37.9 per 100,000) and 2009 (79.4 per 100,000), while the rate in the US decreased from 37.3 per 100,000 to 22.1 per 100,000 over the same period. Fewer African ancestry patients received treatment relative to those of Indian and mixed ancestry (45.7%, 60.3%, and 60.9%, respectively). CONCLUSIONS: Notwithstanding the limitations surrounding data quality, our findings highlight the increasing burden of CaP in TT and the need for improved surveillance and standard of care. Our findings highlight the need for optimized models to project cancer rates in developing countries like TT. This study also provides the rationale for targeted screening and optimized treatment for CaP to ameliorate the rates we report.
Asunto(s)
Neoplasias de la Próstata/epidemiología , Anciano , Países en Desarrollo , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Trinidad y Tobago/epidemiologíaRESUMEN
PURPOSE: Social inequalities in cancer incidence and mortality have been reported in France, but no data are available for the French overseas territories. Our objective was to explore the association between cancer incidence and the socioeconomic level of the residence area in the French West Indies. METHODS: Cancer incidence data were obtained from the cancer registries of Guadeloupe and Martinique (2009-2010). To assess socioeconomic status, we developed a specific index of social deprivation from census data at a small area level. We used Bayesian methods to evaluate the association between cancer incidence and the deprivation index, for all cancers combined and for the major cancer sites. RESULTS: There was no clear association between area-based deprivation and the incidence of all cancers combined. In men, higher area deprivation was associated with a higher incidence of prostate cancer (relative risk (RR) 1.25, 95% credible interval (CI) 1.04-1.49; RR 1.08, CI 0.91-1.29 in the categories of intermediate and high deprivation, respectively, compared to low deprivation), but was not associated with respiratory cancer. Women living in the most deprived areas had a higher incidence of stomach (RR 1.77, CI 1.12-2.89), breast (RR 1.15, CI 0.90-1.45), and cervical (RR 1.13, CI 0.63-2.01) cancers and a lower incidence of respiratory cancer (RR 0.65, CI 0.38-1.11). CONCLUSION: These first results in the French West Indies suggest specific patterns for some cancer sites that need to be further investigated.
Asunto(s)
Neoplasias/epidemiología , Adolescente , Adulto , Anciano , Teorema de Bayes , Femenino , Guadalupe/epidemiología , Humanos , Incidencia , Masculino , Martinica/epidemiología , Persona de Mediana Edad , Sistema de Registros , Riesgo , Clase Social , Adulto JovenRESUMEN
OBJECTIVE: The objective of our study was to determine patterns and cost of imaging tumor surveillance in patients after a benign fine-needle aspiration (FNA) biopsy of the thyroid in a large teaching hospital as well as the rate of subsequent cancer detection. MATERIALS AND METHODS: This cohort study was approved by the appropriate institutional review board and complied with HIPAA. All patients who had a benign thyroid FNA biopsy between January 1, 1999, and December 31, 2003, were identified from an institutional pathology database. We gathered information from electronic medical records on imaging tumor surveillance and subsequent cancer detection. Cost was determined using the facility total relative value unit and the 2014 Hospital Outpatient Prospective Payment System conversion factor. RESULTS: Between January 1, 1999, and December 31, 2003, 1685 patients had a benign thyroid FNA biopsy, 800 (47.5%) of whom underwent follow-up imaging. These patients underwent 2223 thyroid ultrasound examinations, 606 ultrasound-guided thyroid FNA biopsies, 78 thyroid scintigraphy examinations, 168 neck CTs, and 53 neck MRIs at a cost of $529,874, $176,157, $39,622, $80,580, and $53,114, respectively, for a total cost of $879,347 or $1099 per patient. The mean length of follow-up was 7.3 years, during which time 19 (2.4%) patients were diagnosed with thyroid cancer at a cost of $46,281 per cancer. Seventeen (89.5%) were diagnosed with papillary carcinoma and two (10.5%) with Hurthle cell carcinoma. CONCLUSION: Over a 5-year period, about half of the patients who had a benign thyroid FNA biopsy underwent follow-up imaging at considerable cost with a small rate of subsequent malignancy.
Asunto(s)
Biopsia con Aguja Fina/economía , Costos de la Atención en Salud/estadística & datos numéricos , Recurrencia Local de Neoplasia/economía , Neoplasias de la Tiroides/diagnóstico , Neoplasias de la Tiroides/economía , Ultrasonografía/economía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biopsia con Aguja Fina/estadística & datos numéricos , Análisis Costo-Beneficio/economía , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/epidemiología , Pennsylvania/epidemiología , Vigilancia de la Población/métodos , Reproducibilidad de los Resultados , Factores de Riesgo , Sensibilidad y Especificidad , Neoplasias de la Tiroides/epidemiología , Ultrasonografía/estadística & datos numéricos , Espera Vigilante/economía , Espera Vigilante/métodos , Espera Vigilante/estadística & datos numéricos , Adulto JovenRESUMEN
PURPOSE: To analyze cancer incidence, distribution of malignancy, treatment setting and provider specialty of cancer patients, 0-19 years old, in the Comunitat Valenciana, Spain. METHODS/PATIENTS: All incident childhood and adolescent (0-19 years) cancer cases registered in the population-based Comunitat Valenciana Childhood Cancer Registry (RTICV) from 2007 to 2010 were included. Pathological and hematological diagnoses were recoded using the International Classification of Childhood Cancer Third Edition (ICCC-3). Treatment setting and provider specialty were analyzed. RESULTS: 696 patients <20 years were diagnosed with cancer: 513 cases were children (0-14 years) and 183 were adolescents (15-19 years). Overall age-adjusted incidence for 2007-2010 was 176.0 cases per million (95 % CI 162.8-189.2), with incidence being the highest among infants (287.4), followed by 1-4 years (205.5), adolescents (179.9), 10-14 years (150.2) and 5-9 years (140.6). Among adolescents aged 14-19 years, the treatment setting differed by cancer type; 87 % of them were never seen at pediatric oncology units, while 40 % were treated in up to 20 different medical oncology departments in institutions without pediatric oncology expertise. CONCLUSIONS: This is the first population-based epidemiological study carried out in Spain on children and adolescents with cancer. Centralization of care to a small number of specialized centers and thorough pediatric and oncology team collaboration are needed to improve care and survival for adolescents with cancer in our country. We suggest the creation of specific adolescent tumor boards in main tertiary care hospitals, in which adolescents with cancer can benefit from the shared expertise of medical and pediatric specialists.
Asunto(s)
Neoplasias/epidemiología , Neoplasias/terapia , Adolescente , Adulto , Niño , Preescolar , Femenino , Instituciones de Salud/estadística & datos numéricos , Personal de Salud/estadística & datos numéricos , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Oncología Médica/estadística & datos numéricos , España/epidemiología , Especialización/estadística & datos numéricos , Recursos Humanos , Adulto JovenRESUMEN
INTRODUCTION: Information on the epidemiology of childhood cancer in Latin America is limited. The Argentinean Oncopaediatric Registry (ROHA) is a population-based registry active since 2000. This paper describes the 3-year survival experience of children diagnosed with cancer in Argentina during 2000-2007 by major morphological subgroup, age, sex, and geographical region of residence. METHODS: Newly diagnosed paediatric cancer cases are registered in ROHA (estimated coverage is 93% of the country's cases). Three-year overall survival was estimated using Kaplan-Meier methods. Univariate Cox models were used to compare subgroup survival. RESULTS: Between 2000 and 2007, a total of 10,181 new cancer diagnoses in children aged 0-14 years were reported to the registry. Three-year overall survival (95%CI) for all cancers was 61.7% (60.7; 62.7). Specific survival for the most frequent morphological types was: leukaemias 63.3% (61.6; 64.9), lymphomas and related neoplasms 75.3% (72.7; 77.7), brain neoplasms 46.3% (43.9; 48.7), soft-tissue sarcomas 52.3% (48.0; 56.5), neuroblastomas 49.6% (44.6; 54.3), renal tumours 76.7% (72.2; 80.6), and malignant bone tumours 47.2% (42.3; 51.9). Overall survival was associated with age but not sex and varied by geographical region. Compared to other regions, patients who resided in the capital city had a significantly higher survival: 69.6% (65.8; 73.0) versus 63.5% (59.4; 67.4) in Patagonia, 63.2% (61.9; 64.5) in the central region, 58.0% (54.2; 61.7) in Cuyo, 55.6% (52.5; 58.6) in the north-east, and 55.4% (52.4; 58.2) in the north-west (all P values <0.005). CONCLUSIONS: Of children diagnosed with cancer in Argentina, 62% survived at least 3 years after diagnosis. Even though this figure is lower than that reported for more developed countries, survival patterns by diagnosis, age and sex were quite similar. Survival was lower in the two northern regions, which are areas with higher poverty levels.
Asunto(s)
Neoplasias/epidemiología , Adolescente , Argentina/epidemiología , Niño , Preescolar , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Estimación de Kaplan-Meier , Masculino , Pobreza , Modelos de Riesgos Proporcionales , Sistema de RegistrosRESUMEN
Prostate cancer in black men of African descent has a different tumour biology compared to those of other races. Its clinical manifestations depict a more aggressive disease with higher morbidity and mortality. This study proposes, through a literature search, identifying applied laboratory and clinical research in prostate cancer directed to improve outcomes and decrease global disparities of prostate cancer in black men of African descent. This review identified five categories pertinent for research: prostate-specific antigen (PSA) testing for early detection and screening, the potential of epigenetics, cultural determinants and health-seeking behaviours, other biomarkers for prostate cancers, and the economics of treating advanced prostate cancer. The analysis revealed that in developed countries, men of African descent are underrepresented in the sampling pools in both laboratory and clinical research, and thus the applicability and relevance of these results to men of African descent are circumspect. However, developing countries with high populations of black males have limited laboratory and clinical research publications. This is due to limited funding to support research programmes and basic clinical services for early detection and treatment. The study concludes that for the involvement of developing countries in bench research, they should do it in collaboration, like fostering partnerships with credible academic-based institutions and organisations. This requires a realm of transparency, respect, protection of the rights and dignity of the patients, and an equity in participation and sharing of the benefits to be accrued. The current transatlantic and Caribbean collaborations in research, education, and health service delivery in prostate cancer care for men of African descent exemplify the successes of such partnerships.
RESUMEN
For the first time the incidence and mortality of breast cancer were estimated in French Guiana, an overseas French Territory of South America. A certified cancer registry collected exhaustive data on breast cancer between 2003 and 2005. The age-standardized rate of breast cancer was 47.1 per 100 000 women. The age-standardized death rate was 11.0 per 100 000 women. Although the standardized incidence and death rates were lower than in metropolitan France and South America, the ratio between incidence and mortality showed that the prognosis of breast cancer in French Guiana was worse than in metropolitan France (23 deaths per 100 incident cases versus 17 deaths per 100 incident cases, respectively). The demographics of French Guiana, suggests that mass organized screening may benefit from lowering the age of its target population.
RESUMEN
A total of 4981 cancers were recorded in Kingston and St Andrew during the period 2003 - 2007: 2536 in males and 2445 in females. Age standardized rates per 100 000 per year (ASR) were 188.8 and 144.2 for males and females respectively, and are relatively unchanged, compared to the previous report (188.6 for males and 144.2 for females, 1998 - 2002). In males, the leading sites for cancer were prostate, bronchus and large bowel, while in females, they were breast, cervix uteri and large bowel. The leading sites for both genders have been maintained in the same order as in the previous report, but for males, there were increases in the incidence of prostate (ASR 65.5 vs 78.1 per 100 000 per year) and colorectal (ASR 13.7 vs 17.2 per 100 000 per year) cancers and a decrease in the incidence of cancer of the bronchus (ASR 22.8 vs 18.6 per 100 000 per year). For females, there was a modest decrease in incidence of cervical cancer (ASR 19 vs 17.4 per 100 000 per year) while the incidence of cancers of the breast and large bowel remained relatively stable (ASR 40.1 vs 43 per 100 000 per year for breast and ASR 13 vs 12.8 per 100 000 per year for colorectal cancer). These data support the need for urgent institution of formal programmes for prevention and control of cancers of the breast and large bowel in the Jamaican population. Malignancies of unknown primary site were common in both genders and require further investigation.
Un total de 4981 cánceres se registraron en Kingston y Saint Andrew durante el periodo 2003-2007. El número de casos en los varones fue 2536 y 2445 en las hembras. Las tasas estandarizadas por edad (ASR) por 100 000 por año fueron 188.8 y 144.2 para varones y hembras respectivamente, y permanecen relativamente sin cambios en comparación con el informe previo (188.6 para los varones y 144.2 para las hembras, 1998-2002). En los varones, los sitios principales del cáncer fueron la próstata, los bronquios y el intestino grueso, mientras que en las hembras fueron las mamas, el cuello del útero, y el intestino grueso. Los sitios principales para ambos géneros se han mantenido en el mismo orden presentado en el informe anterior, pero para los varones, hubo aumentos en la incidencia del cáncer de próstata (ASR 65.5 vs 78.1 por 100 000 por año) y el cáncer colorrectal (ASR 13.7 vs 17.2 por 100 000 por año), y una disminución en la incidencia del cáncer de bronquios (ASR 22.8 vs 18.6 por 100 000 por año). Para las mujeres, hubo una disminución modesta en la incidencia de cáncer cervical o del cuello uterino (ASR 19 vs 17.4 por 100 000 por año) mientras la incidencia de los cánceres de mama y el intestino grueso permanecía relativamente estable (ASR 40.1 vs 43 por 100 000 por año para el cáncer de mama y ASR 13 vs 12.8 por 100 000 por año para el cáncer colorrectal). Estos datos subrayan la necesidad de instituir de manera urgente programas formales para la prevención y control cánceres de mama e intestino grueso en la población jamaicana. Tumores malignos de sitio primario desconocido fueron comunes en ambos géneros y requieren investigación extensa.
Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Adulto Joven , Neoplasias/epidemiología , Distribución por Edad , Incidencia , Jamaica/epidemiologíaRESUMEN
Introducción: El propósito del presente estudio fue realizar un análisis descriptivo del cáncer oral en el Municipio de Pasto, el cual no había sido caracterizado, analizado y divulgado antes cuando la incidencia de cáncer oral a nivel mundial y nacional incrementa, igualmente la exposición a factores de riesgo. Método: Un estudio retrospectivo descriptivo basado en los 99 casos de cáncer oral reportados en el Registro Poblacional de Cáncer del Municipio de Pasto desde el año 1998 al 2002. La información seleccionada se dividió en dos grupos de variables, la primera correspondiente a los aspectos sociodemográficos y una segunda correspondiente a los aspectos diagnósticos. Resultados: Los 99 casos de cáncer oral tienen una tasa cruda (TC) de 7.82 casos por 100.000 habitantes y una tasa ajustada por edad (TAE) de 8.51 (IC 95%: 7.13-9.9). La incidencia específica o por género fue de 43 nuevos casos en hombres con una TC de 6.54 por 100.000 habitantes y una TAE de 8.02; en mujeres se presentaron 52 nuevos casos con una TC de 9.03 por 100.000 habitantes y una TAE de 8.99. Conclusión: el presente estudio mostró una incidencia del cáncer oral en hombres y mujeres bastante similar, mientras que las otras variables mostraron ser coherentes con los resultados de otros estudios a nivel mundial.
Introduction: The purpose of this study was to carry out a descriptive analysis of oral cancer in the municipality of Pasto. Such study has not been characterized, analyzed and spread before despite the fact that oral cancer incidence level increases worldwide and nationwide as well as the exposure to risk factors. Method: A retrospective study was done. It was based in 99 cases of reported oral cancer in the Cancer Population Registration in the Municipality of Pasto from 1998 to 2002. The selected information was divided in two variable groups. The first one belongs to the socio-demographic aspects and the second belongs to the diagnosis aspects. Results: The 99 cases of oral cancer have a crude rate (CR) of 7.82 cases per 100.000 inhabitants and an age-adjusted rate (AAR) of 8.51(CI 95%: 7.13-9.9). The specific incidence or by genre was of 43 new cases in men with a CR of 6.54 per 100.000 inhabitants and an AAR of 8.02; while 52 new cases with a CR of 9.03 per 100.000 inhabitants and an AAR of 8.99 were presented in women. Conclusion: The present study showed a similar oral cancer incidence in men and women, while other variables showed the coherence with results of worldwide level studies.